Renal Cell Carcinoma of Native Kidney After Renal Transplantation: Clinical Relevance of Early Detection

Transplantation Proceedings

Volumn 41, Issue 10, 2009, Pages 4197-4201

  Filocamo, M T ^a   Zanazzi, M ^b   Li Marzi, V ^a   Guidoni, L ^a   Villari, D ^a   Dattolo, E ^a   Nicita, G ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACQUIRED CYSTIC KIDNEY DISEASE; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CAUSE OF DEATH; COHORT ANALYSIS; DIALYSIS; DRUG SUBSTITUTION; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; KIDNEY CARCINOMA; KIDNEY CYST; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHRECTOMY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SURGICAL PATIENT; TREATMENT DURATION; ULTRASOUND;

CARCINOMA, RENAL CELL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; MALE; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 71249105894     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.08.082     Document Type: Article

References (27)

1. Morath C., Mueller M., Goldschmidt H., et al. Malignancy in renal transplantation. J Am Soc Nephrol 15 (2004) 1582
2. Australia and New Zealand Dialysis and Transplantation Registry, 2006. htpp://www.anzdata.org.au/ Accessed January 2008
3. Kasiske B.L., Snyder J.J., Gilbertson D.T., et al. Cancer after kideny transplantation in the United States. Am J Transplant 4 (2004) 905
4. Dantal J., Hourmant M., Cantarovich D., et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporine regimens. Lancet 351 (1998) 623
5. Danpanich E., and Kasiske B.L. Risk factors for cancer in renal transplant recipients. Transplantation 68 (1999) 1859
6. Gutierrez-Dalmau A., and Campistol J.M. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs 67 (2007) 1167
7. Farivar-Mohseni H., Perlmutter A.E., Wilson S., et al. RCC and end stage renal disease. J Urol 175 (2006) 2018
8. Barrett W., First M., Aron B., et al. Clinical course of malignancies in renal transplant recipients. Cancer 72 (1993) 2186
9. Kasiske B.L., Vazquez M.A., Harmon W.E., et al. Clinical Practice Guidelines of the American Society of Transplantation: recommendations for the outpatient surveillance of renal transplant recipients, VII: Cancers. J Am Soc Nephrol 11 suppl 15 (2000) S1
10. EBPG Expert Group on renal transplantation, European Renal Association-European Dialysis and Transplant Association. Long-term management of the transplant recipient. Nephrol Dial Transplant 17 suppl 43 (2002) 3
11. Kalble T., Lucan M., Nicita G., et al., European Association of Urology. European Association of Urology Guidelines on Renal Transplantation. Eur Urol 47 (2005) 156
12. Chiang Y.J., Chu S.H., Liu K.L., et al. Silent urothelial cancer detected by sonography after renal transplantation. Transplant Proc 38 (2006) 2084
13. Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 7 (1993) 431
14. Vajadic C.M., McDonald S.P., McCredie M.R.E., et al. Cancer incidence before and after kidney transplantation. JAMA 296 (2006) 2823
15. Penn I. Primary kidney tumors before and after renal transplantation. Transplantation 59 (1995) 480
16. Doublet J.D., Peraldi M.N., Gattegno B., et al. RCC of native kidneys: prospective study of 129 renal transplant patients. J Urol 158 (1997) 42
17. Denton M.D., Magee C.C., Ovuworie C., et al. Prevalence of RCC in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int 169 (2003) 2201
18. Neuzillet Y., Lay F., Luccioni A., et al. De novo RCC of native kidney in renal transplant recipients. Cancer 103 (2004) 251
19. Ianhez L.E., Lucon M., Nahas W.C., et al. RCC in renal transplant patients. J Urol 69 (2007) 462
20. Schwarz A., Vatandaslar S., Merkel S., et al. RCC in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol 2 (2007) 750
21. Scandling J.D. Acquired cystic kidney disease and renal cell cancer after transplantation: time to rethink screening?. Clin J Am Soc Nephrol 2 (2007) 621
22. Levine L.A., and Gburek B.M. Acquired cystic disease and renal adenocarcinoma following renal transplantation. J Urol 151 (1994) 129
23. Chapman A.B., Rahbari-Oskouri F.F., et al. Acquired cystic disease of the kidney in adults. UpToDate version 15.1. http://www.uptodate.com Accessed May 10, 2007
24. Oliver III J.H. Clinical indications, recipient evaluation, surgical considerations, and the role of CT and MR in renal transplantation. Radiol Clin North Am 33 (1995) 435
25. Bosniak M.A., Birnbaum B.A., Krinsky G.A., et al. Small renal parenchymal neoplasms: further observations on growth. Radiology 3 (1995) 589
26. Gulanikar A., Daily P.P., Kilambi N.K., et al. Prospective pretransplant ultrasound screening in 206 patients for acquired cystic disease and RCC. Transplantation 66 (1998) 1669
27. Rendon R.A., Stanietzky N., Panzarella T., et al. The natural history of small renal masses. J Urol 161 (2006) 1143